Cargando…

Naming ability in patients with mild to moderate Alzheimer's disease: what changes occur with the evolution of the disease?

OBJECTIVES: Naming deficit is a linguistic symptom that appears in the initial phase of Alzheimer's disease, but the types of naming errors and the ways in which this deficit changes over the course of the disease are unclear. We analyzed the performance of patients with Alzheimer's diseas...

Descripción completa

Detalles Bibliográficos
Autores principales:	Silagi, Marcela Lima, Bertolucci, Paulo Henrique Ferreira, Ortiz, Karin Zazo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo 2015
Materias:	Clinical Science
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4462568/ https://www.ncbi.nlm.nih.gov/pubmed/26106961 http://dx.doi.org/10.6061/clinics/2015(06)07

Ejemplares similares

Analysis of word number and content in discourse of patients with mild to moderate Alzheimer's disease
por: de Lira, Juliana Onofre, et al.
Publicado: (2014)

Language impairment in the moderate stage of dementia due to Alzheimer's disease
por: ORTIZ, Karin Zazo, et al.
Publicado: (2021)

Speech and orofacial apraxias in Alzheimer's disease
por: Cera, Maysa Luchesi, et al.
Publicado: (2013)

Speech and orofacial apraxias in Alzheimer's disease – CORRIGENDUM
por: Cera, Maysa Luchesi, et al.
Publicado: (2013)

Lexical Retrieval or Semantic Knowledge? Which One Causes Naming Errors in Patients with Mild and Moderate Alzheimer's Disease?
por: Salehi, Masoome, et al.
Publicado: (2017)

Characteristics of falls in mild and moderate Alzheimer’s disease
por: Kato-Narita, Eliane Mayumi, et al.
Publicado: (2009)

Mild to moderate ulcerative colitis: Call me by my name
por: Rodríguez‐Lago, Iago, et al.
Publicado: (2022)

Galantamine-ER for the treatment of mild-to-moderate Alzheimer’s disease
por: Seltzer, Ben
Publicado: (2010)

Neuropsychological Rehabilitation in Mild and Moderate Alzheimer’s Disease Patients
por: Ávila, Renata, et al.
Publicado: (2007)

The conceptual relevance of assessment measures in patients with mild/mild-moderate Alzheimer's disease
por: Hartry, Ann, et al.
Publicado: (2018)

Effect of TTP488 in patients with mild to moderate Alzheimer’s disease
por: Burstein, Aaron H, et al.
Publicado: (2014)

Enrichment factors for clinical trials in mild-to-moderate Alzheimer's disease
por: Ballard, Clive, et al.
Publicado: (2019)

Dysphagia is closely related to frailty in mild-to-moderate Alzheimer’s disease
por: Güner, Merve, et al.
Publicado: (2023)

Estimating attrition in mild-to-moderate Alzheimer’s disease and mild cognitive impairment clinical trials
por: Ritchie, Marina, et al.
Publicado: (2023)

Olfactory identification ability in patients with mild cognitive impairment and Alzheimer’s disease
por: Yoshitake, Masashi, et al.
Publicado: (2022)

Diagnosis of Alzheimer’s disease: recommendations of the Scientific Department of Cognitive Neurology and Aging of the Brazilian Academy of Neurology
por: Schilling, Lucas Porcello, et al.
Publicado: (2022)

Predictor Factors of Perceived Health in Family Caregivers of People Diagnosed with Mild or Moderate Alzheimer’s Disease
por: Ruiz-Fernández, María Dolores, et al.
Publicado: (2019)

The Prediction of Response to Galantamine Treatment in Patients with Mild to Moderate Alzheimer’s Disease
por: Ohnishi, Takashi, et al.
Publicado: (2014)

Probabilistic Cost-Effectiveness Analysis of Vaccination for Mild or Moderate Alzheimer’s Disease
por: Yang, Kuen-Cheh, et al.
Publicado: (2016)

Multiple-dose ponezumab for mild-to-moderate Alzheimer's disease: Safety and efficacy
por: Landen, Jaren W., et al.
Publicado: (2017)

Nilvadipine in mild to moderate Alzheimer disease: A randomised controlled trial
por: Lawlor, Brian, et al.
Publicado: (2018)

Heterogeneity in Cost-Effectiveness Analysis of Vaccination for Mild and Moderate Alzheimer’s Disease
por: Lin, Chung-Hsien, et al.
Publicado: (2019)

Cost-effectiveness analysis of the treatment of mild and moderate Alzheimer’s disease in Brazil
por: da Silva, Luciana R., et al.
Publicado: (2018)

Safety and tolerability of GRF6019 in mild‐to‐moderate Alzheimer's disease dementia
por: Hannestad, Jonas, et al.
Publicado: (2020)

Associative Agreement as a Predictor of Naming Ability in Alzheimer's Disease: A Case for the Semantic Nature of Associative Links
por: Zannino, Gian Daniele, et al.
Publicado: (2018)

What is the impact of ongoing statin use on cognitive decline and dementia progression in older adults with mild-moderate Alzheimer disease?
por: Murphy, Claire, et al.
Publicado: (2023)

Good rate of clinical response to cholinesterase inhibitors in mild and moderate Alzheimer's disease after three months of treatment: An open-label study
por: de Miranda, Luis Felipe José Ravic, et al.
Publicado: (2013)

Intelectual demand and formal education as cognitive protection factors in Alzheimer’s disease
por: Wajman, José Roberto, et al.
Publicado: (2010)

Effects of Souvenaid on plasma micronutrient levels and fatty acid profiles in mild and mild-to-moderate Alzheimer’s disease
por: Rijpma, Anne, et al.
Publicado: (2015)

Retrospective case studies of the efficacy of caprylic triglyceride in mild-to-moderate Alzheimer’s disease
por: Maynard, Steven Douglas, et al.
Publicado: (2013)

Acupuncture for patients with mild to moderate Alzheimer’s disease: a randomized controlled trial
por: Jia, Yujie, et al.
Publicado: (2017)

Two randomized controlled trials of SB742457 in mild-to-moderate Alzheimer's disease
por: Maher-Edwards, Gareth, et al.
Publicado: (2015)

Effect of Integrated Cognitive Intervention Therapy in Patients with Mild to Moderate Alzheimer's Disease
por: Jung, Young Hee, et al.
Publicado: (2020)

Textual reading comprehension and naming in Alzheimer’s disease patients
por: Rinaldi, Juciclara, et al.
Publicado: (2008)

Concentration-Dependent Activity of Hydromethylthionine on Cognitive Decline and Brain Atrophy in Mild to Moderate Alzheimer’s Disease
por: Schelter, Bjoern O., et al.
Publicado: (2019)

Alzheimer's disease assessment scale-cognitive 11-item progression model in mild-to-moderate Alzheimer's disease trials of bapineuzumab
por: Samtani, Mahesh N., et al.
Publicado: (2015)

Visuoconstructional Abilities of Patients With Subjective Cognitive Decline, Mild Cognitive Impairment and Alzheimer’s Disease
por: Knechtl, Paula, et al.
Publicado: (2023)

A Color-Picture Version of Boston Naming Test Outperformed the Black-and-White Version in Discriminating Amnestic Mild Cognitive Impairment and Mild Alzheimer's Disease
por: Li, Dan, et al.
Publicado: (2022)

Selective impairment of musical emotion recognition in patients with amnesic mild cognitive impairment and mild to moderate Alzheimer disease
por: Zhou, Shan-Shan, et al.
Publicado: (2019)

Longitudinal multimodal imaging in mild to moderate Alzheimer disease: a pilot study with memantine
por: Schmidt, R, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_u1q5ahci915t79nts6lahi7imc